leisure time -WSS

leisure time

author：explore 2025-10-01 23:57:20 - browse：179

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Caitlin Bernard's story shows physicians can't shy from advocacy

focus

WSS

Providers still hesitate to prescribe buprenorphine, study finds

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

BridgeBio heart drug succeeds in pivotal study

More hospitals are billing patients as online messages surge

Johnson & Johnson sues to stop Medicare negotiation

entertainment

leisure time

entertainment

Virginia high school admissions case could be legal follow

In new study, freeze

Activists slam private health insurers over coverage restrictions

Organ transplantation is at a crossroads. Major reform is needed

In age of alternative facts, a scholarly course on calling out crap

7 of the most gruesome medical devices in history

What does generative AI mean for health care? We asked experts

7 of the most gruesome medical devices in history

Duchenne breakthrough therapy leaves behind pioneering families

Body of missing toddler recovered in Delaware River days after flood: Police

explore

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Twill hunts for pharma partner to market its depression app

Organ transplantation is at a crossroads. Major reform is needed

Johnson & Johnson sues to stop Medicare negotiation

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

hotspot

focus

knowledge

entertainment